RxDoctor Payments Data

David Ngugi

Psychiatric/Mental Health · Lumberton, NCNPI 1679114938

Payments from drug & device makers

$3,932in general payments, 2019–2025

Across 93 payments — averaging $42.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Neuronetics, Inc.$2K
  • AbbVie$929
  • Neurocrine Biosciences, Inc.$119
  • Alkermes, Inc.$81
  • Teva Pharmaceuticals USA, Inc.$74
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$50
  • plus $310 from 15 others

What the payments were for

  • Travel & lodging$1,64742%
  • Food & beverage$2,28558%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,932 in reported general payments places this provider in the 85th percentile of 947 psychiatric/mental health providers in North Carolina.

See all psychiatric/mental health providers in North Carolina

Most prescribed under Part D

DrugClaimsCost to plans & patients
VraylarCariprazine Hcl17$23,373
TrintellixVortioxetine Hydrobromide12$5,527
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl34$3,072
Hydroxyzine Pamoate28$862
Quetiapine Fumarate51$807
Mirtazapine35$652
Escitalopram Oxalate31$498
Buspirone Hcl43$428
Lurasidone Hcl11$361
Sertraline Hcl69$313
Eszopiclone12$260
Lamotrigine25$255
Duloxetine Hcl17$218
Hydroxyzine Hcl18$216
Temazepam12$209

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieVraylar$929$23,37317 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$12$5,52712 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 947 psychiatric/mental health providers in North Carolina.

Other psychiatric/mental health in Lumberton

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →